In PCOS patients, decreased levels of miR-125b-5p lead to increased expression of PAK3 [304], subsequently promoting ERK1/2 activation, which further influences the expression of steroidogenic genes in letrozole-induced mouse GCs and TCs. The gene discussed is MAPK3; the disease is polycystic ovary syndrome.